Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Jianpi Granules is a Traditional Chinese Medicine (TCM) product developed by Jiangsu Kanion Pharmaceutical Co., Ltd., specifically formulated for pediatric use. It is primarily indicated for the treatment of functional dyspepsia and related digestive disorders in children, such as anorexia, abdominal distension, and diarrhea resulting from "spleen deficiency and food stagnation." The formulation is a complex herbal mixture typically containing ingredients such as Astragalus, Codonopsis, Atractylodes, and Hawthorn, which work synergistically to tonify the spleen, harmonize the stomach, and promote digestion. Pharmacologically, the granules are thought to improve gastrointestinal motility and modulate the secretion of digestive enzymes and gastrointestinal hormones like motilin and gastrin, thereby alleviating symptoms of indigestion and improving nutrient absorption in pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiao'er Jianpi Granules.